FRASSOLDATI, ALESSIO
 Distribuzione geografica
Continente #
AS - Asia 178
NA - Nord America 121
EU - Europa 66
SA - Sud America 14
AF - Africa 10
Totale 389
Nazione #
US - Stati Uniti d'America 117
SG - Singapore 70
VN - Vietnam 53
CN - Cina 25
IT - Italia 21
HK - Hong Kong 11
SE - Svezia 10
DE - Germania 8
IN - India 8
BR - Brasile 7
GB - Regno Unito 7
FI - Finlandia 5
CI - Costa d'Avorio 4
IE - Irlanda 4
TG - Togo 4
CH - Svizzera 3
EC - Ecuador 3
FR - Francia 3
CA - Canada 2
JO - Giordania 2
JP - Giappone 2
KR - Corea 2
RU - Federazione Russa 2
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
JM - Giamaica 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
NL - Olanda 1
OM - Oman 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 389
Città #
Singapore 56
Ashburn 17
Chandler 17
Hanoi 13
Hong Kong 10
Ho Chi Minh City 9
San Jose 9
Bagnacavallo 6
Santa Clara 6
Beijing 5
Boardman 5
Abidjan 4
Bologna 4
Dublin 4
Fairfield 4
Helsinki 4
Lomé 4
Southend 4
Bentivoglio 3
Princeton 3
Redondo Beach 3
Amman 2
Bern 2
Guangzhou 2
Guayaquil 2
New York 2
Nuremberg 2
São Paulo 2
Tokyo 2
Turin 2
Tân Tiến 2
Abeokuta 1
Atlanta 1
Bangkok 1
Berlin 1
Bexley 1
Bhopal 1
Bird Island 1
Bogotá 1
Bragado 1
Bremen 1
Bühl 1
Bắc Ninh 1
Bến Tre 1
Cajamar 1
Cambridge 1
Canoas 1
Chennai 1
Chicago 1
Cochabamba 1
Columbus 1
Des Moines 1
Florence 1
Gunsan 1
Haiphong 1
Huizhou 1
Hưng Yên 1
Itabela 1
Jinan 1
Jining 1
Johannesburg 1
Kingston 1
Klamath Falls 1
La Joya de Los Sachas 1
Lappeenranta 1
Las Vegas 1
Lauterbourg 1
Leawood 1
Leicester 1
Los Angeles 1
Ludhiana 1
Mount Vernon 1
Muscat 1
Mérida 1
Nam Định 1
Nanyang 1
North Bergen 1
Olalla 1
Osasco 1
Ottawa 1
Paulista 1
Portsmouth 1
Rach Gia 1
Raleigh 1
Redmond 1
Rimini 1
Saint Louis 1
San Diego 1
San Francisco 1
Santiago 1
Seattle 1
Seoul 1
Shanwei 1
Shijiazhuang 1
Sofia 1
Tam Kỳ 1
Tampines New Town 1
Tashkent 1
Tbilisi 1
Thành Phố Bà Rịa 1
Totale 279
Nome #
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 159
null 99
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (British Journal of Cancer, (2020), 123, 1, (26-32), 10.1038/s41416-020-0845-3) 76
Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging [J Neurooncol (2015) 123, 93-102, DOI 10.1007/s11060-015-1766-5] 35
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET 30
Totale 399
Categoria #
all - tutte 1.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202243 0 0 1 4 3 1 0 11 2 4 11 6
2022/202351 3 7 1 8 4 5 1 2 10 2 5 3
2023/202431 1 4 1 13 2 6 1 1 0 0 2 0
2024/202576 5 11 8 3 12 5 6 5 2 4 2 13
2025/2026193 11 4 8 13 34 7 13 8 61 19 6 9
Totale 399